Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement

American Journal of Cardiology

Volumn 88, Issue 1, 2001, Pages 40-44

  Ageno, Walter ^a,c   Turpie, Alexander G G ^b   Steidl, Luigi ^a   Ambrosini, Fabio ^a   Cattaneo, Roberto ^a   Codari, Romeo L ^a   Nardo, Barbara ^a   Venco, Achille ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; HEPARIN; LEVOTHYROXINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARACETAMOL; RANITIDINE; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; TREATMENT OUTCOME; WARFARIN;

EID: 0035400102     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01582-X     Document Type: Article

References (16)

1. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range
2. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
3. Postoperative care
4. Exaggerated initial response to warfarin following heart valve replacement
5. Studies on coumarin anticoagulant drugs: Initiation of warfarin therapy without a loading dose
6. Protein C response to induction of warfarin treatment after coronary bypass operation
7. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granule release
8. Cardiopulmonary bypass associated hemostatic abnormalities
9. The role of coagulation factors II, V, VII, and X in the response to oral anticoagulants in patients following heart valve replacemement
10. Clinically significant drug interactions with the oral anticoagulants
11. The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient
12. Warfarin therapy in the elderly
13. Effect of ageing upon warfarin dose requirements: A longitudinal study
14. The association of age with dosage requirement for warfarin
15. Effect of age upon the induction and maintenance of anticoagulation with warfarin
16. Ageing and the anticoagulant response to warfarin therapy